title: [Risk profiles for suicide of schizophrenic and depressive inpatients - a psychological autopsy study].
abstract: OBJECTIVE
  This psychological autopsy study investigates suicide risk factors of schizophrenic and depressive inpatients.
  
  
  METHODS
  67 potential risk factors of inpatient suicide were identified by means of literature research and caregiver interviews of schizophrenic and depressive suicidents (1995-2004). The medical records of the suicidents (n = 20) were analysed in respect to the identified risk factors and compared to their respective control group of non-suicidents (n = 20) which was matched by diagnosis, gender, age, year / month of admission and ward. Univariate and multivariate statistical analyses were performed.
  
  
  RESULTS
  In comparison to their respective control group schizophrenic (n = 11) and depressive suicidents (n = 9) differed clearly by their risk profile. Suffering from side effects of medication was found to be a predictor of suicide for schizophrenic inpatients.
  
  
  CONCLUSIONS
  Psychological autopsy studies are indispensable for the construction of diagnosis-specific risk profiles. Reduction of side effects of medication seems to play a larger role in suicide prevention for schizophrenic inpatients than previously assumed.
authors.affiliation: Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie der Universität am Bezirksklinikum Regensburg, Regensburg. tanja.neuner@medbo.de
authors.forename: Tanja
authors.initials: T
authors.lastname: Neuner
authors.forename: Dorothea
authors.initials: D
authors.lastname: Mehlsteibl
authors.forename: Bettina
authors.initials: B
authors.lastname: Hübner-Liebermann
authors.forename: Rita
authors.initials: R
authors.lastname: Schmid
authors.forename: Tanja
authors.initials: T
authors.lastname: Schielein
authors.forename: Helmut
authors.initials: H
authors.lastname: Hausner
authors.forename: Göran
authors.initials: G
authors.lastname: Hajak
authors.forename: Hermann
authors.initials: H
authors.lastname: Spiessl
mesh_terms: D000328:Adult; D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D016022:Case-Control Studies; D003430:Cross-Sectional Studies; D003865:Major Depressive Disorder / Q000175:diagnosis* / Q000188:drug therapy / Q000401:mortality / Q000523:psychology*; D005260:Female; D005858:Germany; D006778:Hospitals, Psychiatric / Q000706:statistics & numerical data*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D012559:Schizophrenia / Q000175:diagnosis* / Q000188:drug therapy / Q000401:mortality; D012565:Schizophrenic Psychology; D012944:Social Support; D012959:Socioeconomic Factors; D013405:Suicide / Q000523:psychology*
chemical_list: D000928:Antidepressive Agents; D014150:Antipsychotic Agents